1. Home
  2. THRD vs BVFL Comparison

THRD vs BVFL Comparison

Compare THRD & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • BVFL
  • Stock Information
  • Founded
  • THRD 2019
  • BVFL 1873
  • Country
  • THRD United States
  • BVFL United States
  • Employees
  • THRD N/A
  • BVFL N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • BVFL Savings Institutions
  • Sector
  • THRD Health Care
  • BVFL Finance
  • Exchange
  • THRD Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • THRD 164.2M
  • BVFL 160.4M
  • IPO Year
  • THRD 2022
  • BVFL N/A
  • Fundamental
  • Price
  • THRD $5.14
  • BVFL $15.35
  • Analyst Decision
  • THRD Hold
  • BVFL
  • Analyst Count
  • THRD 3
  • BVFL 0
  • Target Price
  • THRD $5.00
  • BVFL N/A
  • AVG Volume (30 Days)
  • THRD 1.2M
  • BVFL 23.1K
  • Earning Date
  • THRD 05-14-2025
  • BVFL 04-17-2025
  • Dividend Yield
  • THRD N/A
  • BVFL N/A
  • EPS Growth
  • THRD N/A
  • BVFL N/A
  • EPS
  • THRD N/A
  • BVFL 1.06
  • Revenue
  • THRD N/A
  • BVFL $38,257,000.00
  • Revenue This Year
  • THRD N/A
  • BVFL N/A
  • Revenue Next Year
  • THRD N/A
  • BVFL N/A
  • P/E Ratio
  • THRD N/A
  • BVFL $14.44
  • Revenue Growth
  • THRD N/A
  • BVFL 1.89
  • 52 Week Low
  • THRD $3.18
  • BVFL $10.23
  • 52 Week High
  • THRD $16.94
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • THRD 79.10
  • BVFL 59.61
  • Support Level
  • THRD $5.08
  • BVFL $15.15
  • Resistance Level
  • THRD $5.20
  • BVFL $15.75
  • Average True Range (ATR)
  • THRD 0.11
  • BVFL 0.68
  • MACD
  • THRD 0.13
  • BVFL 0.17
  • Stochastic Oscillator
  • THRD 96.84
  • BVFL 81.98

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: